HOUSTON, May 28, 2019 — Houston-based MedSource, an award winning, full-service clinical research organization, announced the appointment of Scott Hannas as the company’s Vice President, Operations. Hannas will be responsible for continuity in the onsite execution and delivery of work while being a key member of the executive team, building on the Company’s strategic plan. Established to […]
HOUSTON, May 21, 2019 /PRNewswire/ — Houston-based MedSource, continues to retain its position as an award winning, full-service clinical research organization (CRO), with the achievement of two 2019 CRO Leadership Awards presented by Life Science Leader and Industry Standard Research (ISR). This marks the second year MedSource has been recognized as a top performer in the categories of quality and reliability. “We are […]
By: Sondra Simpson, Project Manager, MedSource April 11th is World Parkinson’s Day. This is a day set aside to center public attention on the more than 10 million worldwide who are living with this disease. Each year approximately 60,000 Americans are diagnosed with Parkinson’s disease (PD), and it is estimated that by the year 2020, […]
HOUSTON (March 11, 2019) – Houston-based MedSource continues to expand with the offering of a new business unit; MedSource Staffing Solutions. With a track record of success spanning over 20 years, the complimentary sourcing division of MedSource will continue the dedication to drug development by providing clinical, technical, and executive professionals to Life Science organizations. MedSource’s […]
Did you know that there are more than 7,000 rare diseases known to date? Defined by Congress under the Orphan Drug Act of 1983, the definition of rare disease in the United States is a condition that affects fewer than 200,000 people. In Europe, rare disease is defined as affecting fewer than 1 in 2000 […]
Cancer may have started the fight, but it’s time we finish it. Every one of us knows of a family member, friend, or colleague who has been affected, or we may have been personally affected by cancer. Our goal at MedSource is bigger than one person, or one even company. Our goal is to help save […]
In 2019, approximately 13,170 new cases of invasive cervical cancer will be diagnosed. From these cases, nearly 4,300 women will die from the disease. Once the most common cause of cancer death for American women, cervical cancer now ranks 14th in frequency due to the increased use of the Pap test. Most cases of cervical […]
Within the highly competitive climate of drug development, a creative, strategic and data-driven clinical development plan is essential for navigating the clinical trial landscape. When attempting to deliver a program quickly and effectively, it can be easy to miss opportunities with limited resources, infrastructure, and technological challenges. It is imperative that a clinical research partner […]
Solid growth and expansion for Houston-based CRO furthers drug development for small & mid-sized biotech HOUSTON (October 25, 2018) – The accelerating growth track of Houston-based MedSource was recognized again recently when Biospace named the company as the # 4 fastest growing private life science company in the United States. The Biospace ranking was determined […]
Each year, approximately 300,000 new cases of cancer affect children under the age of 19 worldwide. More than 15,000 of these children are located in the United States alone. Despite the statistics, pediatric cancer researchers and doctors continue to face challenges. Only three new drugs have been approved by the FDA specifically developed to treat […]